Advancing Cancer Research Through Translational Innovation
Cancer research is entering a transformative era driven by breakthroughs in molecular biology, genomics, immunotherapy, artificial intelligence, translational medicine, and targeted therapeutics. The growing integration of basic discovery science with translational and clinical applications is rapidly reshaping oncology research and patient care.
ACRT 2027 is designed to accelerate these scientific advancements by creating a multidisciplinary forum where researchers and industry leaders can exchange ideas, showcase innovations, and establish meaningful collaborations.